Fig. 1
Distribution of JAK2 V617F, MPL, and CALR mutations in patients with essential thrombocythemia (ET) and primary myelofibrosis (PMF)
Fig. 1 | BMC Cancer
Distribution of JAK2 V617F, MPL, and CALR mutations in patients with essential thrombocythemia (ET) and primary myelofibrosis (PMF)